|
|
|
|
- Natif
O., M.Aronson,O.Medalia,T.Moldavsky,E.Sabo,I.Ringel,V.Kravtsov(1997)
Anti-neoplastic activity of paclitaxel
on experimental superficial bladder
cancer: in vivo and in vitro studies.Int
J Cancer, 70,297-301 (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=
PubMed&list_uids=9033631&dopt=Abstract)
- Kravtsov
V., Fabian I.(1996) Automated monitoring
of apoptosis in suspension cell cultures.
Lab Invest,74,557-570
(Abstract - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=
PubMed&list_uids=8780173&dopt=Abstract)
- Kravtsov
V, Greer J,Whitlock J, Koury M (1998)
Use of the microculture kinetic (MiCK)
assay of apoptosis to determine chemosensitivities
of leukemias. Blood,92,968-980
http://www.bloodjournal.org/cgi/content/abstract/92/3/968
- Kravtsov
V, Daniel T, Koury M. (1999) Comparative
analysis of several methodological approaches
to the in vitro studies of cell apoptosis.
Am J Pathology,155,1327-1339.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=
PubMed&list_uids=10514415&dopt=Abstract
- Zang
J, Kravtsov V, Amarnath V, Picklo M,
Graham D, Montine T. (2000) Enhancement
of dopaminergic neurotoxicity by the
mercapturate of dopamine: relevance
to Parkinson's disease. J Neurochem
, 74,970-978.
http://jneurochem.highwire.org/cgi/content/full/74/3/970
- V.Kravtsov,
D.Martincic, J.Whitlock, M.Koury (1996).
Tumor promoter phorbol miristate acetate
modulates kinetics of drug-induced apoptosis
in leukemia cells. The 38th ASH Meeting,
Orlando. Blood, 88:67A
- V.Kravtsov,
M.Koury (1997). Induction of apoptosis
in human myeloid leukemia cells by antimetabolites
and anthracyclines. The 27th Annual
Meeting of ISEH, Cannes.Exp Hematol,
25:852.
- D.Martincic,V.Kravtsov,M.Koury,V.Avramis,J.Whitlock
(1997) Deoxycytidine kinase expression
and activity in Ara-C resistant bcell
lines and samples from newly diagnosed
acute leukemias. The 39th ASH Meeting,
San-Diego, Blood, 90:71a
- V.
Kravtsov, J.Greer, J.Whitlock,M.Koury
(1997)Use of the microculture kinetic
(MiCK) assay of apoptosis to determine
chemosensitivities of leukemiasThe 39th
ASH Meeting, San-Diego, Blood,90:566a
- V.
Kravtsov, J.P. Greer, Y. Shyr, D.J.Haselton,
J.A. Whitlock, S. Goodman, R.S. Stein,
M.J. Koury (1998)Prediction of survival
and responses to chemotherapy in acute
myelogeneous leukemia (AML) by the microculture
kinetic (MiCK) assay of apoptosis. The
40th ASH Meeting, Miami Beach.Blood,92:677a
- D.Martincic,
V.Kravtsov,M.Koury,J.A.Whitlock (1998).
Low level of deoxycytidine kinase expression
and activity is common in samples from
newly diagnosed acute myelogenous leukemia
resistant to ara-C. The 40th ASH Meeting,
Miami Beach.Blood,92:390a
- V.Kravtsov,V.Priego,
J.Reilly, H.Sethi, J.Cooke,W.Smith,M.Koury
(2000) Chemotherapy of myeloid leukemia
directed by a microculture kinetic assay
for apoptosis. The 42nd ASH Meeting.
Blood, 96:3129.
- S.
Kubba, V Kravtsov, M.Koury, R.Kim (2000).
Single nucleotide polymorphisms in MDR1
gene among patients with acute leukemia:
correlation of drug-induced apoptosis
to MDR1 genotype .The 42nd ASH Meeting.
Blood, 96: .
- R.Schultz,
M.Rothenberg, M.Koury, W.Hankins, V.Kravtsov
(2000) Sequence dependence using combination
of Alimta (pemetrexed disodium, LY231514,MTA),
gemcitabine, and oxaliplatin in human
colorectal carcinoma cell lines. Procedings
of the 11th NCI-EORTC-AACR Symposium.
Clin Cancer Res, 6:1078. (http://www.aacr.org/newdrugs00/503.html)
- V.Kravtsov,
J. Greer, Y. Shyr, J. Whitlock, T.,
T.McCurley, Goodman, R. Stein, S.Krantz,
M. Koury (2001) Prediction of survival
in acute non-lymphocytic leukemia (AML).
The 43rd ASH Meeting, Orlando, Blood,98:214b
- V
Kravtsov, D Martincic, J Whitlock, J
Greer, M Koury (1999) Disparity Between
Morphological Evidence of Apoptosis
and Internucleosomal DNA Fragmentation
in Hematologic Malignancies (http://www.asco.org/ac/1,1003,_12-002643-00_18-0017-00_19-0014371,00.asp)
|
|
|
|
 |
|
|
